The Corporate Counsel, Vol. XLV: 2020

November-December 2020 [PDF]

• Annual Season Items (CC Nov-Dec 2020)
• SEC Simplifies Private Offering Exemptions (CC Nov-Dec 2020)
• SEC Overhauls Regulation S-K Financial Disclosures (CC Nov-Dec 2020)

September-October 2020 [PDF]

• SEC Engages in a Flurry of Rulemaking (CC Sept-Oct 2020)
• Regulation FD Turns 20: Our Take (CC Sept-Oct 2020)
• Something to Look Forward to in 2021: Less Non-Issuer Financial Information (CC Sept-Oct 2020)

July-August 2020 [PDF]

• In Memoriam: Marty Dunn (CC July-Aug 2020)
• What's in a Name? The SEC Amends "Accelerated Filer" and "Large Accelerated Filer" Definitions (CC July-Aug 2020)
• The Curious Case of Public Companies and the PPP (CC July-Aug 2020)
• COVID-19 Disclosure: What Does the SEC Want to See in Your MD&A? (CC July-Aug 2020)
• COVID-19: Chief Accountant's Statement Emphasizes Financial Reporting Process (CC July-Aug 2020)
• "Going Concern" Rears Its Ugly Head (CC July-Aug 2020)
• SEC Amends Proxy Rules to Address Voting Advice by Proxy Advisors (CC July-Aug 2020)

May-June 2020 [PDF]

• A Word From Our Founder - What We Each Can Be Doing Now (CC May-June 2020)
• Forward-Looking COVID-19 Disclosure: Watch Your Step! (CC May-June 2020)
• Corp Fin CDIs and FAQs on COVID-19 Exemptive Order (CC May-June 2020)
• Planning for Continuity of Board Operations During the COVID-19 "Emergency" (CC May-June 2020)

March-April 2020 [PDF]

• A Disclosure Framework for the Coronavirus (CC Mar-Apr 2020)
• The SEC Weighs In (CC Mar-Apr 2020)
• Coronavirus Disclosure Considerations (CC Mar-Apr 2020)
• Executives in Trouble: Is Disclosure of Uncharged Conduct Required? (CC Mar-Apr 2020)
• Other Potential Disclosure Considerations (CC Mar-Apr 2020)
• "Test the Waters for All" Means WKSIs, Too! (CC Mar-Apr 2020)
• What WKSIs Can Do Under Rule 163 (CC Mar-Apr 2020)
• The "Test the Waters" Rule 163B Alternative (CC Mar-Apr 2020)
• Mix & Match? Rule 163B is Non-Exclusive (CC Mar-Apr 2020)
• Conclusion: WKSIs Should Keep Rule 163B in Mind (CC Mar-Apr 2020)
• It's Here: 2020 Executive Compensation Disclosure Treatise (CC Mar-Apr 2020)
• Early Bird Registration! Our "Proxy Disclosure/Executive Pay Conferences" (CC Mar-Apr 2020)

January-February 2020 [PDF]

• Annual Season Items (CC Jan-Feb 2020)
• Time for a Risk Factor Tune-Up? (CC Jan-Feb 2020)
• Getting Back to Basics (CC Jan-Feb 2020)
• Rooting Out Hypothetical Risk Factor Disclosure (CC Jan-Feb 2020)
• Brexit - What's Next? (CC Jan-Feb 2020)
• LIBOR Transition (CC Jan-Feb 2020)
• IP and Technology Risks Associated with International Business Operations (CC Jan-Feb 2020)
• Tariffs and Trade (CC Jan-Feb 2020)
• World Health Concerns (CC Jan-Feb 2020)
• Data Privacy (CC Jan-Feb 2020)
• Omitting Third Year Comparisons from MD&A: The Staff Weighs In (CC Jan-Feb 2020)
• More on MD&A: The Commission's Interpretive Release on KPIs and Metrics (CC Jan-Feb 2020)
• A Brave New World for Confidential Treatment: Asking for Forgiveness Instead of Permission (CC Jan-Feb 2020)
• A New Streamlined Confidential Treatment Process Dawns (CC Jan-Feb 2020)
• Self-Executing Rules (CC Jan-Feb 2020)
• Staff Review of Exhibits (CC Jan-Feb 2020)
• New Streamlined Extension Confidential Treatment Request Procedures (CC Jan-Feb 2020)
• Enter the Supremes: The Impact of Argus Leader (CC Jan-Feb 2020)
• The SEC's New Confidential Treatment Request Guidance (CC Jan-Feb 2020)
• 2020 Executive Compensation Disclosure Treatise (CC Jan-Feb 2020)
• Early Bird Registration! Our "Proxy Disclosure/Executive Pay Conferences" (CC Jan-Feb 2020)